loading
Skip to main content
  • U.S. Department of Health & Human Services(link is external)
National Institutes of Health (NIH) - Turning Discovery into Health
  • Virtual Tour
  • En Español

Site Menu

  • Home
  • Health Information
    • Health Care Providers & Facilities(link is external)
    • Health Info Lines
    • HealthCare.gov(link is external)
    • Science Education Resources
    • NIH Clinical Research Trials and You
    • Talking to Your Doctor

    More »

    Quick Links

    • MedlinePlus Health Info
    • NIH News in Health
    • Wellness Toolkits
  • Grants & Funding
    • Grants Home Page
    • Find Funding
    • Due Dates
    • How to Apply
    • About Grants
    • Policy & Compliance
    • Grants News/Blog
    • Contracts
    • Loan Repayment

    More »

    Quick Links

    • RePORT
    • eRA Commons
    • NIH Common Fund
  • News & Events
    • News Releases
    • Digital Media Kits
    • Media Resources
    • Media Contacts
    • Images and B-roll
    • Events
    • Social Media

    More »

    Quick Links

    • NIH News in Health
    • NIH Research Matters
    • NIH Record
  • Research & Training
    • Medical Research Initiatives
    • Science Highlights
    • Science Education
    • Research in NIH Labs & Clinics
    • Training Opportunities
    • Library Resources
    • Research Resources
    • Clinical Research Resources
    • Safety, Regulation and Guidance

    More »

    Quick Links

    • PubMed
    • Stem Cell Information
    • OppNet
    • NIDB
    • NIH Blueprint for Neuroscience Research
  • Institutes at NIH
    • List of Institutes and Centers
    • NIH Office of the Director
    • Directors of NIH Institutes and Centers
    • NIH Institute and Center Contact Information

    More »

    Quick Links

    • NCI
    • NEI
    • NHLBI
    • NHGRI
    • NIA
    • NIAAA
    • NIAID
    • NIAMS
    • NIBIB
    • NICHD
    • NIDCD
    • NIDCR
    • NIDDK
    • NIDA
    • NIEHS
    • NIGMS
    • NIMH
    • NIMHD
    • NINDS
    • NINR
    • NLM
    • CC
    • CIT
    • CSR
    • FIC
    • NCATS
    • NCCIH
  • About NIH
    • Who We Are
    • What We Do
    • Jobs at NIH
    • Visitor Information
    • Frequently Asked Questions
    • Contact Us

    More »

    Quick Links

    • The NIH Director
    • Take the Virtual Tour
    • NIH…Turning Discovery Into Health®
    • Impact of NIH Research
    • Science, Health, and Public Trust

You are here

Home » News & Events » News Releases

News Releases

News Release

Thursday, December 5, 2019

Gay, bisexual men increasingly agree: HIV “Undetectable Equals Untransmittable”

Yet transmission-risk misunderstandings persist, finds large NIH-supported study.

an image of pills A variety of antiretroviral drugs used to treat HIV beneath the slogan “U=U.” NIAID

Extensive evidence from HIV prevention research studies has firmly established that “Undetectable Equals Untransmittable,” or U=U. This means that people living with HIV who achieve and maintain an undetectable viral load — the amount of virus in their blood — by taking antiretroviral therapy (ART) as prescribed do not sexually transmit HIV to others. The U.S. Centers for Disease Control and Prevention estimates this strategy is 100% effective(link is external) against the sexual transmission of HIV.

Now, a new study of nearly 112,000 men who have sex with men in the United States has found increasing acceptance of the U=U message in this population. Overall, 54% of HIV-negative participants and 84% of participants with HIV correctly identified U=U as accurate. The study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Study results were published online today in the Journal of Acquired Immune Deficiency Syndromes.

“U=U has been validated repeatedly by numerous studies as a safe and effective means of preventing the sexual transmission of HIV,” said Anthony S. Fauci, M.D., NIAID Director. “The increased understanding and acceptance of U=U is encouraging because HIV treatment as prevention is a foundation of efforts to end the epidemic in the United States and around the world. This public health message has the power to reduce stigma, protect the health of people living with HIV and prevent sexual transmission of HIV to others.”

Researchers led by H. Jonathon Rendina, Ph.D., M.P.H., at Hunter College of the City University of New York, collected data from secure online surveys promoted on social media and mobile dating apps from November 2017 through September 2018. By analyzing the responses of self-identified sexual minority men, researchers found that approximately 55% of participants responded “completely accurate” or “somewhat accurate” to the question: “With regard to HIV-positive individuals transmitting HIV through sexual contact, how accurate do you believe the slogan Undetectable = Untransmittable is?” 

Acceptance of U=U was far stronger among participants who self-reported to be living with HIV (84%) compared to HIV-negative participants (54%) and those who did not know their HIV status (39%). Researchers found U=U acceptance had increased over time by comparing the data to findings from a similar study by the same group that analyzed data collected in 2016 and early 2017. Among the 12,200 sexual minority men surveyed at that time, only 30% of HIV-negative participants and 64% of participants living with HIV agreed that U=U was completely or somewhat accurate.

In the current study, HIV-negative participants who reported seeking HIV testing and prevention services, as well as those taking daily pre-exposure prophylaxis (PrEP), were more likely to believe U=U was accurate. These findings suggest that U=U acceptance correlates to more frequent interactions with HIV prevention services. Among respondents with HIV, those who reported excellent adherence to ART were more likely to agree that U=U is accurate compared to those who reported “less than excellent” adherence or not being on ART at all.

The online survey also asked respondents to use a graduated scale from 0% (“no risk”) to 100% (“complete risk”) to rate the risk of a man whose HIV was undetectable transmitting the virus to his HIV-negative partner through either insertive or receptive anal sex without a condom. While studies confirm that a person whose HIV is suppressed does not transmit the virus through sexual activity, only 10% of all respondents rated the transmission risk as zero when the insertive partner has undetectable virus. Similarly, only 14% of respondents rated transmission risk as zero when HIV in the receptive partner is undetectable.

Among those who agreed that U=U was “completely accurate,” only 31% and 39% believed transmission risk is zero when the insertive or receptive partner, respectively, has undetectable virus. However, acceptance of U=U was associated with lower perceived risk of HIV transmission through any form of condom-less anal sex.

“A growing number of sexual minority men believe that U=U is accurate, but our data suggest that most still overestimate the risk of HIV transmission from an undetectable partner, which may be because people have trouble understanding the concept of risk,” said Dr. Rendina, the lead author on the study. “All published studies point to undetectable viral load as being the most effective method to date of preventing sexual HIV transmission, but most of our messaging has focused on the level of risk being zero rather than describing it in terms of effectiveness, which is the way we usually talk about condoms and PrEP.”

All data collected in the online survey was confidential and self-reported. Study participants represented all U.S. states and were of various races and ethnicities, including 14% Black and 24% Latino. Participants ranged in age from 13 to 88 years old with a median age of 32. About 79% identified as gay, 18% as bisexual, and 3% as queer. Approximately 1% of respondents identified as transgender.

Earlier this year, Dr. Fauci and his colleagues wrote about the strength of scientific validation for the HIV treatment as prevention strategy and U=U in a JAMA commentary. The efficacy of treatment as prevention was first verified on a large scale by the NIH-funded HPTN 052 clinical trial, which showed that no linked HIV transmissions occurred among serodifferent heterosexual couples when the partner living with HIV had a durably suppressed viral load. Subsequently, the PARTNER 1 and 2 and Opposites Attract studies confirmed these findings and extended them to male-male couples. As described by authors of the current study, the independent non-profit organization Prevention Access Campaign launched the U=U slogan in 2016 to promote awareness of these scientific findings.

Importantly, U=U refers only to the prevention of sexually transmitted HIV; condoms are still needed to prevent the transmission of other sexually transmitted infections. 

This research was supported in part by NIAID (UG3-AI133674), the National Institute of Mental Health (R01-MH114735, co-funded UG3-AI133674), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U19-HD089875, U19-HD089875-03S2, co-funded UG3-AI133674) and the National Institute on Drug Abuse (R01-DA041262, R34-DA043422, R01-DA045613, K01-DA039030), all part of NIH.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH…Turning Discovery Into Health®

Reference

H Rendina et al. Growing acceptability of Undetectable = Untransmittable but widespread misunderstanding of transmission risk: Findings from a very large sample of sexual minority men in the United States. Journal of Acquired Immune Deficiency Syndromes DOI: 10.1097/QAI.0000000000002239 (2019).

###

Institute/Center

National Institute of Allergy and Infectious Diseases (NIAID)

Contact

Judith Lavelle (link sends e-mail)
301-402-1663

Connect with Us

  • Subscribe to news releases
  • RSS Feed

Connect with Us

  • Contact Us
  • X(link is external)
  • Facebook(link is external)
  • Instagram(link is external)
  • YouTube(link is external)
  • Flickr(link is external)
  • More Social Media from NIH

Footer

  • NIH Home
  • Virtual Tour
  • En Español
  • Visitor Information
  • Frequently Asked Questions
  • Privacy Policy
  • Disclaimers
  • Accessibility
  • NIH Website Archives
  • Nondiscrimination Notice
  • Freedom of Information Act
  • No Fear Act
  • HHS Vulnerability Disclosure(link is external)
  • Office of Inspector General(link is external)
  • USA.gov(link is external)

NIH…Turning Discovery Into Health®

National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892

U.S. Department of Health and Human Services(link is external)

Back to Top